Company / EPS (Diluted)
Imunon, Inc. EPS (Diluted) History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$5.03
FY2023
5-year range
-$10.08 / -$0.68
FY2019-FY2023
Trend
-
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) returned to growth in FY2023 after 2 years of decline, reaching $-5.03.
Based on SEC 10-K filings.
-5.03 in FY2023.
Declined from $-0.77 to $-5.03 over the past 3 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak eps (diluted) was recorded in FY2019.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$5.03 | - |
| FY2022 | - | - |
| FY2021 | -$10.08 | -1209.1% |
| FY2020 | -$0.77 | -13.2% |
| FY2019 | -$0.68 | +75.0% |
| FY2018 | -$2.72 | -186.3% |
| FY2015 | -$0.95 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026